[ { "@graph" : [ { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#pubinfo" } ] } ], "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#Head" }, { "@graph" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_5844", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#association", "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_5844" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "https://identifiers.org/drugbank:DB01079" } ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "\"ZELNORM is contraindicated in patients with: A history of myocardial infarction (MI), stroke, transient ischemic attack (TIA), or angina [see Warnings and Precautions (5.1) A history of ischemic colitis or other forms of intestinal ischemia [see Warnings and Precautions (5.2) Severe renal impairment (eGFR< 15 mL/min/1.73 m 2 [see Use in Specific Populations (8.6) Moderate and severe hepatic impairment (Child-Pugh B or C) [see Use in Specific Populations (8.7) A history of bowel obstruction, symptomatic gallbladder disease, suspected sphincter of Oddi dysfunction, or abdominal adhesions [see Adverse Reactions (6.2) Hypersensitivity to tegaserod [see Adverse Reactions (6.2) ZELNORM is contraindicated in patients with: A history of myocardial infarction, stroke, transient ischemic attack, or angina. ( 4 5.1 A history of ischemic colitis or other forms of intestinal ischemia. ( 4 5.2 Severe renal impairment (eGFR< 15 mL/min/1.73 m 2 4 8.6 Moderate or severe hepatic impairment (Child-Pugh B or C). ( 4 8.7 A history of bowel obstruction, symptomatic gallbladder disease, suspected sphincter of Oddi dysfunction, or abdominal adhesions. ( 4 Hypersensitivity to tegaserod. ( 4\"" } ], "https://w3id.org/biolink/vocab/provided_by" : [ { "@id" : "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/relation" : [ { "@id" : "https://schema.org/MedicalContraindication" } ] }, { "@id" : "https://identifiers.org/drugbank:DB01079", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Drug" } ] } ], "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#assertion", "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ] } ], "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM", "http://purl.org/dc/terms/created" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2021-08-23T19:01:06.583+02:00" } ], "http://purl.org/dc/terms/creator" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ { "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ { "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ { "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "HMpAN/ZLAiirJ0dlGD2UuaPZ7LKEBwrf2JA4ZsjRPcg2IJ0rov5ynpWH9odQraW2JKDIExFrpyJqG7XB53q9ysnb6ceOxqO1r1BhZH20ivER7b12CBzWRThwvtaYTJxibEkRo5mG6J7G2XX+oPaTclLx92lBGH8NkaFT7RTPUhI=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM" } ] } ], "@id" : "http://purl.org/np/RA0UFXrlBNciWJp7kKelPDD3ZvmW6fpjsaBKB0m_YNuDM#pubinfo" } ]